Showing results (41-50 of 782) with videos related to
Sort By:
Pageof 79
The Lancet. HIV|July 21, 2022
Advancing the prevention and treatment of HIV in children: priorities for research and developmentMartina Penazzato, Claire L Townsend, Nadia A Sam-Agudu, et al.The Lancet. HIV|July 21, 2022
What babies need: accelerating access to current and novel antiretroviral drugs in neonates through pharmacokinetic studiesTom G Jacobs, Stef Schouwenburg, Martina Penazzato, et al.The Lancet. HIV|April 30, 2022
Immunogenicity and safety of a SARS-CoV-2 recombinant spike protein nanoparticle vaccine in people living with and without HIV-1 infection: a randomised, controlled, phase 2A/2B trialShabir A Madhi, Dhayendre Moodley, Sherika Hanley, et al.The Lancet. HIV|October 12, 2019
Safety and immunogenicity of a multivalent HIV vaccine comprising envelope protein with either DNA or NYVAC vectors (HVTN 096): a phase 1b, double-blind, placebo-controlled trialGiuseppe Pantaleo, Holly Janes, Shelly Karuna, et al.The Lancet. HIV|October 16, 2019
Effects of tesamorelin on non-alcoholic fatty liver disease in HIV: a randomised, double-blind, multicentre trialTakara L Stanley, Lindsay T Fourman, Meghan N Feldpausch, et al.The Lancet. HIV|February 5, 2022
Trends in suicide mortality among people with HIV after diagnosis during 2012-18: a retrospective, national cohort study in ChinaFangfang Chen, Chang Cai, Shengfeng Wang, et al.The Lancet. HIV|February 12, 2022
HIV care cascade and associated factors among men who have sex with men, transgender women, and genderqueer individuals in Zimbabwe: findings from a biobehavioural survey using respondent-driven samplingTiffany G Harris, Yingfeng Wu, Lauren E Parmley, et al.The Lancet. HIV|February 13, 2022
Intertwined epidemics: progress, gaps, and opportunities to address intimate partner violence and HIV among key populations of womenNabila El-Bassel, Trena I Mukherjee, Claudia Stoicescu, et al.The Lancet. HIV|March 31, 2022
Scaling up access to HIV pre-exposure prophylaxis (PrEP): should nurses do the job?Heather-Marie A Schmidt, Robin Schaefer, Van Thi Thuy Nguyen, et al.The Lancet. HIV|October 17, 2021
Initiation of long-acting cabotegravir plus rilpivirine as direct-to-injection or with an oral lead-in in adults with HIV-1 infection: week 124 results of the open-label phase 3 FLAIR studyChloe Orkin, Enrique Bernal Morell, Darrell H S Tan, et al.Pageof 79